Search - tctmd.com

Displaying 61 - 74 of 74

Sort: Relevancy | Date

News Industry News

Isis Pharmaceuticals Announces Initiation of an Investigator-Sponsored Phase 2 Study of ISIS-TTR Rx in Patients with TTR Cardiomyopathy Amyloidosis

December 16, 2015

News Industry News

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

September 28, 2015

News Industry News

Medtronic Study Detects Gene Associated with Sudden Cardiac Death

August 31, 2015

News Industry News

ISIS Pharmaceuticals Reports Data from ISIS-TTR Rx in patients with Transthyretin Amyloid-Related Cardiomyopathy

July 27, 2015

Presentation TCT 2013

Fish Oil and CHD Benefit: Is It the Dose, Type, Genetics or Blood Level? (EPA, DHA, FADS)

Presenter: H. Robert Superko

October 31, 2013

News Daily News

La Respuesta Antiplaquetaria de los Afroamericanos Desfavorecida por una Variante Genética, la ‘Raza’

June 07, 2013

News Daily News

African Americans’ Antiplatelet Response Handicapped by Gene Variant, ‘Race’

June 07, 2013

News Daily News

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Jason Kahn

December 17, 2012

Presentation TCT 2012

Platelet Reactivity, Genetics, and Thienopyridine Responsiveness: Theoretical and Real-world Implications

Presenter: Matthew Price

October 22, 2012

News Daily News

JAMA Letters Continue Debate Over Genotype, Clopidogrel Response

Caitlin E. Cox

April 12, 2012

News Daily News

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

April 10, 2012

News Daily News

Análisis Genético CHARISMA: Las Variantes del CYP2C19 Influyen Poco a Nivel Clínico

April 10, 2012

News Daily News

Younger Women with AMI Less Likely to Present with Chest Pain Than Men

Yael L. Maxwell

February 20, 2012

News Daily News

Genetic Variant Predicts Revascularization, Disease Progression in Young MI Patients

July 13, 2011

Advertisement

Isis Pharmaceuticals Announces Initiation of an Investigator-Sponsored Phase 2 Study of ISIS-TTR Rx in Patients with TTR Cardiomyopathy Amyloidosis

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

Medtronic Study Detects Gene Associated with Sudden Cardiac Death

ISIS Pharmaceuticals Reports Data from ISIS-TTR Rx in patients with Transthyretin Amyloid-Related Cardiomyopathy

Fish Oil and CHD Benefit: Is It the Dose, Type, Genetics or Blood Level? (EPA, DHA, FADS)

La Respuesta Antiplaquetaria de los Afroamericanos Desfavorecida por una Variante Genética, la ‘Raza’

African Americans’ Antiplatelet Response Handicapped by Gene Variant, ‘Race’

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Platelet Reactivity, Genetics, and Thienopyridine Responsiveness: Theoretical and Real-world Implications

JAMA Letters Continue Debate Over Genotype, Clopidogrel Response

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

Análisis Genético CHARISMA: Las Variantes del CYP2C19 Influyen Poco a Nivel Clínico

Younger Women with AMI Less Likely to Present with Chest Pain Than Men

Genetic Variant Predicts Revascularization, Disease Progression in Young MI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content